Overview
U.S. healthcare REIT's Q1 net income rose sharply, beating analyst expectations
Company completed Janus Living IPO, generating $880 mln in proceeds for growth initiatives
Healthpeak repurchased 5.9 mln shares for about $100 mln in April 2026
Outlook
Healthpeak raises 2026 diluted EPS guidance to $0.46–$0.50 from $0.34–$0.38
Company lowers 2026 diluted Nareit FFO per share guidance to $1.68–$1.72 from $1.70–$1.74
Healthpeak reaffirms 2026 same-store cash NOI growth outlook at (1.0%)–1.0%
Result Drivers
JANUS LIVING IPO - Completion of Janus Living IPO generated $880 mln in proceeds and is expected to drive earnings growth through senior housing investments
SENIOR HOUSING ACQUISITIONS - $714 mln in senior housing acquisitions contributed to Janus Living as part of formation transactions, supporting consolidated revenue growth
LEASING ACTIVITY - Outpatient medical and lab leasing remained strong, with 1.2 mln sq ft of new and renewal outpatient medical leases and positive releasing spreads
Company press release: ID:nBwcdp7NVa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Net Income
Beat
$193.48 mln
$17.04 mln (5 Analysts)
Q1 Adjusted FFO
$316.85 mln
Q1 FFO
$301.52 mln
Q1 Dividend
$0.14
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy", 10 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialized reits peer group is "buy"
Wall Street's median 12-month price target for Healthpeak Properties Inc is $18.00, about 10.5% above its May 4 closing price of $16.29
The stock recently traded at 78 times the next 12-month earnings vs. a P/E of 66 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)